Albumin Infusion Guidance

Context-Dependent Infusion Rates

The American Society of Clinical Oncology recommends pamidronate 90 mg administered over 4-6 hours for patients with extensive bone disease and severe renal impairment (serum creatinine ≥3.0 mg/dL or creatinine clearance <30 mL/min) 1
When pamidronate is reinstituted after unexplained albuminuria, it should be given over ≥4 hours at doses not exceeding 90 mg every 4 weeks, as recommended by the American Society of Clinical Oncology 1
The International Society of Nephrology suggests that some centers use regular albumin infusion protocols of 1-4 g/kg/day, which may be administered over extended periods when using central venous lines, for patients with congenital nephrotic syndrome 2
The frequency and dosage of albumin infusion should be based on clinical indicators of hypovolemia rather than serum albumin levels, according to the International Society of Nephrology 2

The American Burn Association recommends albumin administration after the first 6 hours of management in patients with >30% total body surface area burns, with doses of 1-2 g/kg/day to maintain albumin levels >30 g/L 3, 4
The European Association for the Study of the Liver suggests that albumin (20-40 g/day) is given during terlipressin treatment for hepatorenal syndrome, with the rationale for albumin achieved after a short course (1-2 days) 5

The American Society of Nephrology notes that fluid overload is a documented complication, particularly with higher doses or rapid administration in cirrhotic patients, with doses exceeding 87.5 g (>4×100 mL of 20% albumin) potentially associated with worse outcomes due to fluid overload 6

The American College of Physicians recommends assessing patient volume status first, with hypovolemic patients able to tolerate faster infusion rates, and euvolemic patients limited to 2 mL/min (≈120 mL/hour for 25% albumin) 6
The International Society of Nephrology suggests considering the specific indication, such as post-paracentesis, spontaneous bacterial peritonitis, or nephrotoxic drugs (pamidronate), when determining the infusion rate 1, 2, 6

The European Society of Intensive Care Medicine advises against using serum albumin levels alone to guide infusion rate, as volume status is the critical determinant 2
The American Thoracic Society recommends avoiding rapid infusion in patients with normal or elevated blood volumes, as this increases pulmonary edema risk 3, 5, 6
The Society of Critical Care Medicine suggests monitoring for fluid overload continuously, particularly when total doses exceed 87.5 g 6